Page last updated: 2024-11-02

piracetam and Alloxan Diabetes

piracetam has been researched along with Alloxan Diabetes in 10 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
"nefiracetam was also blocked by i."1.31Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. ( Rashid, MH; Ueda, H, 2002)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stepanović-Petrović, R1
Micov, A1
Tomić, M1
Pecikoza, U1
Zhilyuk, VI1
Levykh, AE1
Mamchur, VI2
Zhiliuk, VI1
Pavlov, SV1
Akman, L1
Erbas, O2
Akdemir, A1
Yavasoglu, A2
Taskiran, D2
Kazandi, M1
Reda, HM1
Zaitone, SA1
Moustafa, YM1
Oltulu, F1
Yılmaz, M1
Pandey, S1
Garabadu, D1
Rashid, MH1
Ueda, H1
Ardid, D1
Lamberty, Y1
Alloui, A1
Coudore-Civiale, MA1
Klitgaard, H1
Eschalier, A1
Bentue-Ferrer, D1
Philouze, V1
Pape, D1
Reymann, JM1
Allain, H1
Van den Driessche, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake[NCT01168687]46 participants (Actual)Interventional2008-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Standard Alcoholic Drinks Per Treatment Period

The primary outcome of this study is to determine the effect of levetiracetam on alcohol consumption as measured by change in # of drinks during each treatment period. (NCT01168687)
Timeframe: During each 14 day treatment period

Interventionnumber of drinks per treatment period (Mean)
All Subjects (n = 46) Placebo41.2
All Subjects (n = 46) Levetiracetam45.4

Other Studies

10 other studies available for piracetam and Alloxan Diabetes

ArticleYear
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
    Psychopharmacology, 2017, Volume: 234, Issue:11

    Topics: Amines; Analgesics; Animals; Anticonvulsants; Antioxidants; Cyclohexanecarboxylic Acids; Diabetes Me

2017
A study of the mechanisms for antiaggregant activity of pyrrolidone derivatives in rats with chronic hyperglycemia.
    Bulletin of experimental biology and medicine, 2014, Volume: 156, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Male; Nitric Oxide Synthase; Piracetam; Platelet Aggregati

2014
[Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
    Eksperimental'naia i klinicheskaia farmakologiia, 2015, Volume: 78, Issue:2

    Topics: Alloxan; Amnesia; Animals; Avoidance Learning; Cerebral Cortex; Cognition; Cytidine Diphosphate Chol

2015
Levetiracetam ameliorates ovarian function in streptozotocin-induced diabetic rats.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:8

    Topics: Animals; Anti-Mullerian Hormone; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glutathione

2015
Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
    European journal of pharmacology, 2016, Jan-15, Volume: 771

    Topics: Amines; Animals; Astrocytes; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetes

2016
Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy.
    Diabetes research and clinical practice, 2016, Volume: 114

    Topics: Animals; Apoptosis; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Model

2016
Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
    Cellular and molecular neurobiology, 2017, Volume: 37, Issue:5

    Topics: Amnesia; Animals; Blood Glucose; Brain Diseases; Brain-Derived Neurotrophic Factor; Choline; Diabete

2017
Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Analgesia; Animals; Diabetes Mellitus, Experimental; Hyperalgesia; Male; Mice; Mice, Inbred Strains;

2002
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
    European journal of pharmacology, 2003, Jul-18, Volume: 473, Issue:1

    Topics: Acute Disease; Analgesics; Animals; Carbamazepine; Chronic Disease; Constriction, Pathologic; Diabet

2003
Comparative evaluation of scavenger properties of exifone, piracetam and vinburnine.
    Fundamental & clinical pharmacology, 1989, Volume: 3, Issue:4

    Topics: Animals; Benzophenones; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Free Radicals; Mal

1989